☆ 4.8 Article

SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies

JOURNAL OF CLINICAL INVESTIGATION (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda et al.

Summary: The study found that individuals recovered from mild COVID-19 develop sustained SARS-CoV-2-specific immunological memory for at least 3 months, including immunoglobulin antibodies, neutralizing plasma, and memory B and T cells. These memory lymphocytes exhibit potent antiviral function, aiding in immune defense.

CELL (2021)

Add to Collection

Editorial Material Immunology

B cell memory: understanding COVID-19

Isaak Quast et al.

Summary: Immunological memory is crucial for protecting against reinfection, with antibodies produced by B cells playing a key role in this defense mechanism. Understanding how B cell memory is generated, its efficacy, and persistence, particularly in response to SARS-CoV-2, is essential for achieving protective immunity through vaccination.

IMMUNITY (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley et al.

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.

CELL (2021)

Add to Collection

Article Allergy

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Carlo Cervia et al.

Summary: The study found that severe COVID-19 patients experienced a significant increase in SARS-CoV-2 antibody titers after symptom onset, especially with high IgA titers, while mild cases may exhibit transient production of SARS-CoV-2-specific antibodies. Interestingly, some healthcare workers with negative serum antibody titers showed SARS-CoV-2-specific IgA in mucosal fluids with virus-neutralizing capacity in some cases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Cell Biology

The effect of spike mutations on SARS-CoV-2 neutralization

Chloe Rees-Spear et al.

Summary: The study found that emerging variants of the coronavirus may lead to reduced neutralization by antibodies induced by vaccines or previous infection, but some samples still retain effectiveness. This highlights the importance of real-time monitoring of emerging mutations and their impact on vaccine efficacy.

CELL REPORTS (2021)

Add to Collection

Review Medicine, General & Internal

Antibody Response After SARS-CoV-2 Infection and Implications for Immunity A Rapid Living Review

Irina Arkhipova-Jenkins et al.

Summary: The synthesis of evidence suggests that most adults develop detectable levels of IgM and IgG antibodies after SARS-CoV-2 infection, with IgM levels peaking early in the disease course and IgG levels remaining detectable for a significant period of time.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Matthew McCallum et al.

Summary: The study identifies 41 human monoclonal antibodies that recognize the N-terminal domain of the SARS-CoV-2 spike protein and exhibit strong neutralizing activity. These antibodies inhibit cell-to-cell fusion, activate effector functions, and protect animals from virus challenge, highlighting the importance of NTD-specific neutralizing antibodies for protective immunity and vaccine development. Several SARS-CoV-2 variants with mutations in the NTD supersite suggest ongoing selective pressure on the virus.

CELL (2021)

Add to Collection

Article Immunology

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

Carl Graham et al.

Summary: The interaction between the SARS-CoV-2 Spike receptor binding domain (RBD) and the host cell receptor ACE2 is crucial for viral entry, with RBD being the main target for neutralizing antibodies. Mutations in RBD, N-terminal domain (NTD), and S2 subunits of Spike have been found in circulating SARS-CoV-2 variants. This study isolates and characterizes monoclonal antibodies targeting different epitopes on RBD, NTD, and S2 to understand how these mutations affect antigenicity and neutralization resistance.

IMMUNITY (2021)

Add to Collection

Article Medicine, Research & Experimental

Durable SARS-CoV-2 B cell immunity after mild or severe disease

Clinton O. Ogega et al.

Summary: Research has shown that individuals infected with SARS-CoV-2 develop S-RBD-specific, class-switched rMBCs, regardless of disease severity. This provides evidence for sustained B cell-mediated immunity against the virus.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Infectious Diseases

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers

Ross J. Harris et al.

Summary: The study found that trends in SARS-CoV-2 antibodies after infection are highly dependent on the assay used, with different methods showing varying antibody dynamics. Ongoing serosurveillance using multiple assays is critical for monitoring the course and long-term progression of SARS-CoV-2 antibodies.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Delphine Planas et al.

Summary: The ability of convalescent sera from individuals with coronavirus disease 2019 and those vaccinated with BNT162b2 to neutralize SARS-CoV-2 variants B1.1.7 and B.1.351 decreases, but increases after two vaccine doses. The study found that the B.1.1.7 and B.1.351 variants may have acquired partial resistance to neutralizing antibodies generated by natural infection or vaccination, particularly in individuals with low antibody levels. This suggests that the B.1.351 variant may pose a greater risk of infection in immunized individuals.

NATURE MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

Matthew K. Siggins et al.

Summary: Respiratory viruses contribute significantly to the global burden of disease, and understanding the role of immunity in protection and resolution of diseases caused by these viruses, particularly in the face of challenges like COVID-19, is crucial.

TRENDS IN MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

Jackson S. Turner et al.

Summary: The study found that individuals who had recovered from mild SARS-CoV-2 infections showed rapid decline of serum anti-SARS-CoV-2 spike protein antibodies in the first 4 months after infection, followed by a more gradual decrease over the following 7 months but remaining detectable at least 11 months after infection. This suggests that mild infection with SARS-CoV-2 can induce robust antigen-specific, long-lived humoral immune memory in humans.

NATURE (2021)

Add to Collection

Article Medicine, Research & Experimental

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection

Natalia Sherina et al.

Summary: The study shows that 85% of samples from COVID-19 patients had anti-SARS-CoV-2 antibodies within 4 weeks of symptom onset, while specific IgG antibodies and plasma neutralizing activities remained relatively stable up to 6 months after diagnosis. 80% of samples collected at 6-8 months after symptom onset still had anti-SARS-CoV-2 IgG antibodies, and specific memory B and T cell responses continued to develop and persist.

MED (2021)

Add to Collection

Article Health Care Sciences & Services

Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020

Anna Jeffery-Smith et al.

Summary: The study found high rates of asymptomatic infection and transmission even in care homes with no reported cases of COVID-19, with higher seropositivity rates compared to RT-PCR positivity highlighting the true extent of silent outbreaks.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Review Cell Biology

Why does COVID-19 disproportionately affect older people?

Amber L. Mueller et al.

AGING-US (2020)

Add to Collection

Article Medicine, General & Internal

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

Temet M. McMichael et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Immunology

Age-related factors that affect B cell responses to vaccination in mice and humans

Daniela Frasca et al.

IMMUNOLOGICAL REVIEWS (2020)

Add to Collection

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Jennifer A. Juno et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Matthew C. Woodruff et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Understanding protection from SARS-CoV-2 by studying reinfection

Julie Overbaugh

NATURE MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Seasonal coronavirus protective immunity is short-lasting

Arthur W. D. Edridge et al.

NATURE MEDICINE (2020)

Add to Collection

Article Microbiology

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Immunology

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Roltgen et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Kevin W. Ng et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Gemma E. Hartley et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England

Shamez N. Ladhani et al.

ECLINICALMEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020

Shamez N. Ladhani et al.

ECLINICALMEDICINE (2020)

Add to Collection

Review Immunology

B cell memory: building two walls of protection against pathogens

Munir Akkaya et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection

Carl W. Davis et al.

CELL (2019)

Add to Collection

Review Immunology

B Cell Dysfunction Associated With Aging and Autoimmune Diseases

Shiliang Ma et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Immunology

Generation of memory B cells and their reactivation

Takeshi Inoue et al.

IMMUNOLOGICAL REVIEWS (2018)

Add to Collection

Article Medicine, Research & Experimental

PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection

Loghman Salimzadeh et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Medicine, Research & Experimental

Circulating and intrahepatic antiviral B cells are defective in hepatitis B

Alice R. Burton et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Review Immunology

Age (autoimmunity) associated B cells (ABCs) and their relatives

Swati Phalke et al.

CURRENT OPINION IN IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus

Scott A. Jenks et al.

IMMUNITY (2018)

Add to Collection

Article Multidisciplinary Sciences

In situ click chemistry generation of cyclooxygenase-2 inhibitors

Atul Bhardwaj et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Immunology

Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation

Denise Lau et al.

SCIENCE IMMUNOLOGY (2017)

Add to Collection

Article Cell Biology

T-bet-expressing B cells during HIV and HCV infections

James J. Knox et al.

CELLULAR IMMUNOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response

James J. Knox et al.

JCI INSIGHT (2017)

Add to Collection

Article Immunology

Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection

Burton E. Barnett et al.

JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Article Immunology

Effects of Ageing on the Immune System: Infants to Elderly

R. Valiathan et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Article Immunology

The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations

Daniela Frasca et al.

VACCINE (2016)

Add to Collection

Review Cell Biology

How T follicular helper cells and the germinal centre response change with age

Michelle A. Linterman

IMMUNOLOGY AND CELL BIOLOGY (2014)

Add to Collection

Article Immunology

Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza

Stefano Rinaldi et al.

VACCINE (2014)

Add to Collection

Article Biochemical Research Methods

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses

Maja Jahnmatz et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2013)

Add to Collection

Article Immunology

Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants

Whitney E. Purtha et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Add to Collection

Article Hematology

B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy

Susan Moir et al.

BLOOD (2010)

Add to Collection

Review Immunology

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity

Ian J. Amanna et al.

IMMUNOLOGICAL REVIEWS (2010)

Add to Collection

Article Medicine, General & Internal

Duration of humoral immunity to common viral and vaccine antigens

Ian J. Amanna et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Add to Collection

Article Biochemical Research Methods

Quantitation of rare memory B cell populations by two independent and complementary approaches

Ian J. Amanna et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2006)

Add to Collection

Article Biochemical Research Methods

Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system

S Crotty et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2004)

Add to Collection

Article Biochemical Research Methods

Single epitope multiple staining to detect ultralow frequency B cells

SE Townsend et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.